Curis News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

14.11.24	Curis Inc Q3 Loss Decreases, Beats Estimates (RTTNews)
01.08.24	Curis Inc Q2 Loss Decreases, But Misses Estimates (RTTNews)
08.07.24	Will Curis' TakeAim Trials Hit The Mark? (RTTNews)
07.05.24	Curis Inc Q1 Loss beats estimates (RTTNews)
08.02.24	Curis Inc Q4 sales decline (RTTNews)
05.12.23	Curis Inks Deal With Florida University For Emavusertib/Pembrolizumab Combination Study In Melanoma (RTTNews)
02.11.23	Curis Inc Q3 Loss decreases, beats estimates (RTTNews)
06.07.23	Curis: FDA Removes Partial Clinical Hold On TakeAim Leukemia Study (RTTNews)
04.05.23	Curis Inc Q1 Loss decreases, but misses estimates (RTTNews)
27.04.23	Curis to Release First Quarter 2023 Financial Results and Hold Conference Call on May 4, 2023 (PR Newswire)
06.04.23	Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
03.04.23	Curis to Present at Upcoming Healthcare Conferences in April (PR Newswire)
09.03.23	Curis Reschedules Fourth Quarter 2022 Business Update and Conference Call (PR Newswire)
12.12.22	Curis Reports Positive Updated Data From Ongoing Phase 1a Study Of Emavusertib (RTTNews)
09.11.22	Curis Inc Q3 Loss increases, but beats estimates (RTTNews)
30.08.22	Curis Says FDS Allows Additional Patient Enrollment For TakeAim Leukemia Study (RTTNews)
18.08.22	Curis: FDA Lifts Partial Clinical Hold On TakeAim Lymphoma Study (RTTNews)
04.08.22	Curis Inc Q2 loss increases in line with estimates (RTTNews)
05.05.22	Curis Inc Q1 Loss increases, misses estimates (RTTNews)
11.04.22	Curis: FDA Places Partial Clinical Hold On TakeAim Lymphoma Study - Quick Facts (RTTNews)
04.04.22	Curis Reports Partial Clinical Hold On TakeAim Leukemia Phase 1/2a Study (RTTNews)
04.04.22	Pre-market Movers: ISAA, TWTR, GTIM, SPI, IVDA… (RTTNews)
24.02.22	Curis Inc Q4 Loss increases, misses estimates (RTTNews)
09.11.21	Curis Inc Q3 Earnings Summary (RTTNews)
03.08.21	EARNINGS SUMMARY: Details of Curis Inc Q2 Earnings Report (RTTNews)
03.08.21	Curis Reports Second Quarter 2021 Financial Results (PR Newswire)
27.07.21	Curis to Release Second Quarter 2021 Financial Results and Hold Conference Call on August 3, 2021 (PR Newswire)
07.07.21	Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
25.06.21	Curis, Inc. Set to Join Russell 2000®, 3000® and Microcap® Indexes (PR Newswire)
16.06.21	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Curis, Inc. - CRIS (PR Newswire)
11.06.21	Curis Announces Positive Updated Data from Ongoing Phase 1/2 Study of CA-4948 Monotherapy in Patients with Relapsed or Refractory Acute Myeloid Leukemia and Myelodysplastic Syndromes (PR Newswire)
12.05.21	EARNINGS SUMMARY: Details of Curis Inc Q1 Earnings Report (RTTNews)
12.05.21	Curis Provides Updated Trial Data Of Blood Cancer Treatment (RTTNews)
19.04.21	Curis Gets FDA Orphan Drug Designation For CA-4948 For Treatment Of AML And MDS (RTTNews)
16.03.21	EARNINGS SUMMARY: Details of Curis Inc Q4 Earnings Report (RTTNews)
09.02.21	Curis Doses First Patient In Phase 1 Study Of CA-4948 (RTTNews)
02.02.21	Curis Initiates Phase 2 LUCAS Study Of CA-4948 For Treatment Of Anemia (RTTNews)
14.12.20	Curis Announces Closing Of Public Offering; Expects Net Proceeds Of Approx. $159.1 Mln (RTTNews)
13.12.20	Week Ahead In Pharma: FDA Decision, Review Of COVID-19 Vaccine, Data Readouts (MRNA, BCRX, ARVN...) (RTTNews)
09.12.20	Pre-market Movers In Healthcare Sector: RCKT, LPCN, PRPH, KZIA, CRIS… (RTTNews)
08.12.20	Stock Alert: Curis Soars 400% On Positive Leukemia Trial Results (RTTNews)
10.11.20	EARNINGS SUMMARY: Details of Curis Inc Q3 Earnings Report (RTTNews)
07.08.20	Pre-market Movers In Healthcare Sector: KZIA, ZSAN, BNGO, VXRT, ADTX... (RTTNews)
04.08.20	EARNINGS SUMMARY: Details of Curis Inc Q2 Earnings Report (RTTNews)
07.07.20	Curis Doses First Patient In Phase 1 Trial Evaluating CA-4948 - Quick Facts (RTTNews)
10.06.20	Stock Alert: Curis Hits New 52-week High (RTTNews)
10.06.20	Curis : FDA Clears IND Application For Monoclonal Anti-VISTA Antibody CI-8993 (RTTNews)
12.05.20	EARNINGS SUMMARY: Details of Curis Inc Q1 Earnings Report (RTTNews)
19.03.20	EARNINGS SUMMARY: Details of Curis Inc Q4 Earnings Report (RTTNews)
12.09.19	Curis Promotes Bill Steinkrauss As CFO - Quick Facts (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Curis Inc Registered Shs

Aktien Top/Flop

Meistgelesene Nachrichten